We are seeking partner and alliance globally to co-develop new medicine, as well as licensing-in right of manufacturing, commercializing, marketing and distributing the medical products in China mainland market.
Our foremost interest is in neurology, cardiology, diabetes, infection, oncology, liver disease, and gynecology related disease. We may also be interested in products prescribed by other niche physician categories.
Our strategy is to acquire or in-license prescription pharmaceutical products for distribution or the whole manufacure and distribution rights in the mainland China which are promotion-sensitive and which are:
We are open to all different types of deals ranging from agent and distribution in Chinese medicine market to acquisitions the whole licensing-in right. Lokis has a flexible and can-do approach to doing deals and promoting products. Lokis will be the best optimal products partner with oversea products to smoothly launch in Chinese medicine market.
Name | Description |
---|---|
Pharma licensing | In-licensing (demand) |